• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Optimize EP Launches CaRM Cardiac Device Data Management Platform

    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030

    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR

    Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation

    Moon Surgical Expands Leadership Team
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    K-Tube Technologies

    Concise Engineering

    Medbio LLC

    MW Life Sciences

    Spectrum Plastics Group
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Qosina Corp.

    K-Tube Technologies

    Creganna Medical, part of TE Connectivity

    Unicep

    PTI Engineered Plastics Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Theranos: Not Long for the Business World?

    ...

    Theranos: Not Long for the Business World?
    Elizabeth Holmes, the chief executive officer and founder of Theranos, at a Palo Alto, Calif. event in 2013. (DoD photo by Glenn Fawcett/Released)
    Related CONTENT
    • Imec Developing Five Minute COVID Test
    • 3. Abbott
    • Medical Devices and the Political Climate of 2018: An Update from the Swamp
    • Medtech M&A Off to a Strong Start in 2018
    • LivaNova Clinical Study to Evaluate Treatment Outcomes for Microburst VNS Therapy System
    Michael Barbella, Managing Editor05.03.18
    It won’t be long now.

    With a skeleton staff, dwindling finances, a sullied reputation, and a disgraced leader under criminal investigation, embattled blood testing firm Theranos Inc. seems veritably destined for a terrible, miserable, no good, very sad ending.

    In mid-April, The Wall Street Journal reported the company furloughed most of its remaining workforce in a desperate attempt to stave off bankruptcy, leaving roughly two dozen employees (at most) to run the business. The downsizing is the latest setback in a series of damning headlines, U.S. government probes, and failed pivots that have precipitated the firm’s self-implosion over the last few years.

    The most recent round of layoffs occurred in the wake of fraud allegations against Theranos CEO Elizabeth Holmes and former president Ramesh “Sunny” Balwani. A U.S. Securities and Exchange Commission (SEC) complaint filed on March 14 accuses the pair of misleading investors by raising more than $700 million through “exaggerated or false statements” about the company’s technology and financial performance. Holmes quickly settled with the SEC without admitting any wrongdoing, agreeing to pay a $500,000 penalty; surrender most of her Theranos stock; and accept a decade-long ban on corporate board service. Theranos’ independent directors released a brief statement when the settlement was announced, declaring, “The company is pleased to bring this matter to a close and looks forward to advancing its technology.”

    Balwani, contrarily, is fighting the SEC charges. He became company president in 2009 after guaranteeing a line of credit for the financially struggling Holmes, according to the SEC complaint.

    Theranos’ fairy tale-like existence began to unravel in October 2015 with a Journal expose that questioned the authenticity of the company’s proprietary technology, an iMedicine vision, of sorts, for blood testing. Its miniLab blood analyzer (the size of a desktop computer) purportedly could run hundreds of different diagnostic tests on just a few drops of blood, thereby eliminating the need for long needles and multiple vials. Holmes boasted that the technology would be “faster, cheaper, and more accurate” than alternatives, and claimed the U.S. Department of Defense had used the tests on Afghanistan battlefields. Neither assertion was true though, the SEC contends.

    The deception, however, extended beyond the corner office: The SEC charges that Theranos employees wrote flattering reports about the firm’s own products and affixed pharmaceutical company logos to them to make it appear as if the drugmakers endorsed Theranos’ technology.

    One of the most flagrant examples of Theranos’ deceit involved claims the blood analyzer could process more than 1,000 Current Procedural Terminology codes and that Theranos had developed a technological solution for an additional 300 codes. “But Theranos’ analyzers never performed comprehensive testing or processed 1,000 CPT codes in its clinical lab,” the SEC countered in its complaint. “In fact, as far as Holmes knew, or was reckless in not knowing, Theranos’ clinical lab used the TSPU [Theranos Sample Processing Unit] only to perform 12 of the tests offered to patients.”

    Since its exposure as a fraud, Theranos has voided nearly 1 million blood test results in Arizona and California, and shut two laboratories where its blood analyzers were producing unreliable data. Late last year, the company secured a $100 million loan from private equity firm Fortress Investment Group LLC but received only $65 million up front, the Journal reported.

    To access the rest of the funding, Theranos must meet certain product and operational milestones, including obtaining U.S. Food and Drug Administration approval for a Zika blood test. Such approval could prove difficult, however, due to unreliable test results.

    The layoffs announced last month should keep Theranos afloat through July, but Holmes is hoping to secure the company’s long-term future with additional investments. In an April 10 email detailed by the Journal, Holmes appealed to investors for additional funding, offering to sell a large stake of the firm at a favorable price. She may have trouble, though, finding financiers who are willing to forgive (and forget) her past sins so quickly.

    “If what she’s been charged with is true, she’s a criminal who should be in prison,” one tech investor told Vanity Fair in March. “I highly doubt Elizabeth Holmes set out to be a fraud—much in the same way that I don’t think Bernie Madoff’s business plan from day one was to run a Ponzi scheme. Does that even matter? All founders are faced with difficult choices, and the vast majority of them make the right call, erring on the side of transparency and honesty. To dismiss her wrongdoing is to discount all the founders who, knowing they had the wrong answer for an investor, made the hard choice to tell the truth, knowing it might be the final nail for their company.”

    Some venture capitalists blamed Theranos’ downfall partly on a business model that “encourages” companies to raise massive amounts of money without ever developing a product or proving market need. One investor even faulted the stockholders themselves.

    “It’s on her [Holmes], it’s on the company, it’s on the investors, and the board members who didn’t ask any of the right questions,” one Silicon Valley financier noted to Vanity Fair. “Or, evidently, any questions at all.”  
    Related Searches
    • 2015
    • layoffs
    • data
    • technology
    Related Knowledge Center
    • Diagnostics
    Suggested For You
    Imec Developing Five Minute COVID Test Imec Developing Five Minute COVID Test
    3. Abbott 3. Abbott
    Medical Devices and the Political Climate of 2018: An Update from the Swamp Medical Devices and the Political Climate of 2018: An Update from the Swamp
    Medtech M&A Off to a Strong Start in 2018 Medtech M&A Off to a Strong Start in 2018
    LivaNova Clinical Study to Evaluate Treatment Outcomes for Microburst VNS Therapy System LivaNova Clinical Study to Evaluate Treatment Outcomes for Microburst VNS Therapy System
    Software Validation: How It Should Be Done Software Validation: How It Should Be Done
    FDA FDA's Expansion of 510(k) Program Seeks to End Predicate Testing for Some Devices
    Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating
    Theranos’ Holmes and Former President Balwani Charged with Massive Fraud Theranos’ Holmes and Former President Balwani Charged with Massive Fraud
    AtriCure Names Board Chairman AtriCure Names Board Chairman
    FDA Expands Heart Valve Approval to Include Size for Newborn Patients FDA Expands Heart Valve Approval to Include Size for Newborn Patients
    AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife System AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife System
    FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit
    Qosina Announces Scott Herskovitz as New President and Chief Executive Officer Qosina Announces Scott Herskovitz as New President and Chief Executive Officer
    Teleflex Completes CEO Transition Teleflex Completes CEO Transition

    Related Columns

    • Diagnostics
       How COVID-19 is Reshaping the Diagnostics Testing Sector

      How COVID-19 is Reshaping the Diagnostics Testing Sector

      The short-term impact on the diagnostics sector is readily apparent as the pandemic has fueled overwhelming demand for effective SARS-CoV-2 testing solutions.
      Eric Williams, Managing Director, Capstone Headwaters 11.04.20

    • Diagnostics
      A Breath of Fresh Air for COVID-19 Testing

      A Breath of Fresh Air for COVID-19 Testing

      One of the latest COVID-19 testing innovations has recently emerged from Israel’s Technion-Israel Institute of Technology—a coronavirus breath test.
      Sam Brusco, Associate Editor 09.01.20

    • Diagnostics
      ‘Pandemic Drone’ Spots COVID-19 Symptoms

      ‘Pandemic Drone’ Spots COVID-19 Symptoms

      About three months ago, drone-making company Draganfly began to strategize how drones might be able to help against COVID-19.
      Sam Brusco, Associate Editor 06.04.20


    • Diagnostics
      Gaining a Clearer Picture of Hitachi

      Gaining a Clearer Picture of Hitachi

      Diagnostic imaging is gaining the attention of many in healthcare as the technologies shrink in size and become available to those outside the hospital.
      Sean Fenske, Editor-in-Chief 04.01.20

    • Diagnostics
      From Genome Sequencing to the World’s First Portable MRI

      From Genome Sequencing to the World’s First Portable MRI

      Dr. Jonathan Rothberg has risen about as high as a scientist can, save for the Nobel Prize.
      Sam Brusco, Associate Editor 11.04.19

    • Diagnostics
      Elizabeth Holmes: The Making of a Pop Culture Icon

      Elizabeth Holmes: The Making of a Pop Culture Icon

      Despite keeping a relatively low profile this year (not by choice), Elizabeth Holmes’ celebrity status has continued to grow.
      Michael Barbella, Managing Editor 10.08.19


    • Cardiovascular | Diagnostics | Digital Health | Patient Monitoring
      Cardiac Care on the Can

      Cardiac Care on the Can

      ...
      Sam Brusco, Associate Editor 04.03.19

    • Diagnostics | Digital Health
      Google’s Search for Direction in Healthcare

      Google’s Search for Direction in Healthcare

      ...
      Michael Barbella, Managing Editor 03.07.19

    • Diagnostics | Materials | Patient Monitoring
      Diabetes Management and the Role of Adhesives

      Diabetes Management and the Role of Adhesives

      ...
      Del R. Lawson, Ph.D., R&D manager, Critical and Chronic Care Solutions Division, 3M 06.04.18


    • Diagnostics | Digital Health
      A Past Glimpse Into the Future

      A Past Glimpse Into the Future

      ...
      Michael Barbella, Managing Editor 06.04.18

    • Diagnostics | R&D & Design
      Designing Diagnostic Consumables: Custom or Off-the-Shelf?

      Designing Diagnostic Consumables: Custom or Off-the-Shelf?

      ...
      Steve Maylish, Fusion Biotec, and Richard Spero, Redbud Labs 10.05.17

    • Diagnostics | Surgical
      Crash Test Dummies with Synthetic Beating Hearts

      Crash Test Dummies with Synthetic Beating Hearts

      ...
      Sam Brusco, Associate Editor 07.26.17


    • Cardiovascular | Diagnostics
      Changing Administrations and the Strategy for Value-Based Growth in Medtech

      Changing Administrations and the Strategy for Value-Based Growth in Medtech

      ...
      Maria Shepherd, Medi-Vantage 07.26.17

    • Diagnostics | Digital Health | Patient Monitoring
      Medical Auto-Pilot: Medtech’s Focus on Digital Therapeutics

      Medical Auto-Pilot: Medtech’s Focus on Digital Therapeutics

      ...
      Bryan Hughes, Director, P&M Corporate Finance 07.26.17

    • Diagnostics | Digital Health | Electronics | Patient Monitoring
      The Future of Medical Wearables

      The Future of Medical Wearables

      ...
      Mike Bolduc, Global Marketing Manager, Industrial and Medical Segments, C&K 06.06.17


    Trending
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Medtech Matters: Talking Robotic Surgery With Zimmer Biomet
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Moon Surgical Expands Leadership Team
    Breaking News
    • Optimize EP Launches CaRM Cardiac Device Data Management Platform
    • U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    • FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    • Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation
    • Moon Surgical Expands Leadership Team
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    P&G, L'Oréal & Amorepacific Make News at CES
    Three Form Vertical Beauty Alliance
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login